Thursday, Sep 10, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Health | Who Warns Risk Related To Omicron As Very High

WHO warns risk related to Omicron as ‘very high’

The overall global risk related to the new VOC Omicron is assessed as very high. Given mutations that may confer immune escape potential and possibly transmissibility advantage

By M. Sai Gopal
Updated On - 29 November 2021, 10:42 PM
WHO warns risk related to Omicron as ‘very high’
whatsapp facebook twitter telegram

Hyderabad: The World Health Organisation (WHO) on Monday has warned that the overall global risk related to the new ‘Variant of Concern’ (VOC) Omicron is ‘very high’.   The top global health organisation, which released a technical paper on Omicron on Monday, said that the potential of the Omicron variant to spread globally is high.

“The overall global risk related to the new VOC Omicron is assessed as very high. Given mutations that may confer immune escape potential and possibly transmissibility advantage, the likelihood of potential further spread of Omicron at the global level is high,” the WHO said.


In the technical paper, the WHO risk assessment of Omicron VOC said that it has the potential to trigger future surges. “Depending on these characteristics, there could be future surges of Covid-19, which could have severe consequences, depending on a number of factors including where surges may take place.,” the WHO risk assessment said.

In the same technical paper, the WHO has also come-up with certain recommendations i.e. priority actions that countries must immediately take to contain further spread of Omicron.

“Enhance surveillance and sequencing efforts to better understand circulating SARS-CoV-2 variants, including Omicron. Where capacity exists, perform field investigations and laboratory assessments to improve understanding of the characteristics of Omicron. This should include community testing to detect if Omicron is circulating in the community,” the WHO said.

The top health organisation has also urged member countries to focus on completing the Covid vaccine administration drive. “Accelerate Covid-19 vaccination coverage as rapidly as possible, especially among populations designated as high priority who remain unvaccinated or are not yet fully vaccinated.  Use a risk-based approach to adjust international travel measures in a timely manner,” the WHO advisory said.

The WHO maintained that ‘Omicron was a highly divergent variant with a high number of mutations, including 26-32 in the spike, some of which are concerning and may be associated with immune escape potential and higher transmissibility’.

The uncertainties, however, surrounding Omicron including its transmissibility, whether it can escape immunity, how well vaccines protect against infection, transmission, clinical disease of different degrees of severity, have continued, WHO added.

It also clarified that as more evidence on the nature and behaviour of Omicron variant emerges, more clarity will emerge around the key questions.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Omicron
  • WHO

Related News

  • Congo’s Ebola outbreak becomes deadliest on record, kills over 2,300

    Congo’s Ebola outbreak becomes deadliest on record, kills over 2,300

  • Congo’s Ebola outbreak began months before official declaration: WHO

    Congo’s Ebola outbreak began months before official declaration: WHO

  • WHO classifies three widely used medicines, including a common BP drug, as Group 1 carcinogens

    WHO classifies three widely used medicines, including a common BP drug, as Group 1 carcinogens

  • Four Covid-19 patients under treatment in Kolkata as doctors urge vigilance

    Four Covid-19 patients under treatment in Kolkata as doctors urge vigilance

Latest News

  • BRS leaders detained as police step up preventive action amid ongoing Assembly session

    8 minutes ago
  • ‘You’ve got it wrong guys’: UK’s anti-immigrant protesters mistake Pakistan U19 cricket team for asylum seekers

    22 minutes ago
  • Thai police officer kills wife at kindergarten, surrenders after 18-hour standoff

    23 minutes ago
  • Gold, silver trade mixed ahead of US inflation data, Fed Reserve decision

    28 minutes ago
  • Viyona Fintech Ready to Onboard Banks on NPCI’s eNACHLite as In-App e-Mandate Replaces Browser Redirect

    36 minutes ago
  • Stalin responds to CM Vijay’s jaw gesture, recalls MISA agony

    38 minutes ago
  • US Department of Homeland Security advertisement asking ‘Mr Singh’ to self-deport kicks off row

    44 minutes ago
  • Congress accuses govt of ‘distorting’ Census 2027

    50 minutes ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App